Neuromodulation Market worth $10.68 billion by 2030
The report "Neuromodulation Market by Technology (Internal, External), Stimulation Type (Spinal Cord, Deep Brain, Vagus Nerve Stimulation), Application (Ischemia, Depression, Epilepsy, Obesity), End User (Hospitals, ASCs, Clinics) & Region - Global Forecast to 2030", was valued at an estimated USD 6.81 billion in 2025 and is projected to reach USD 10.68 billion by 2030, at a CAGR of 9.4%.
Browse 500 market data Tables and 53 Figures spread through 366 Pages and in-depth TOC on "Neuromodulation Market by Technology (Internal, External), Stimulation Type (Spinal Cord, Deep Brain, Vagus Nerve Stimulation), Application (Ischemia, Depression, Epilepsy, Obesity), End User (Hospitals, ASCs, Clinics) & Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
The growth of the neuromodulation market is driven by key factors. A rising prevalence of neurological disorders and an increasing geriatric population contribute to the growing incidence of neurological conditions. Additionally, increasing collaborations among device manufacturers, healthcare providers, and research institutions to develop neuromodulation devices will propel the market forward. Emerging markets are also expanding access to healthcare, opening new opportunities for growth and adoption.
By technology, the internal neuromodulation segment is expected to grow at the fastest rate in the neuromodulation market across the forecast period.
The neuromodulation technology market is categorized into two main types: internal neuromodulation and external neuromodulation. The internal neuromodulation segment held the largest market share in 2024. Internal neuromodulation has an advantage due to its ability to deliver targeted, long-term therapy for chronic neurological, urological, and pain conditions. Advanced implantable technologies such as rechargeable systems, closed-loop feedback, and programmable stimulation improve efficacy, safety, and patient compliance. Strong clinical evidence and favorable reimbursement policies further drive widespread adoption over non-invasive options alternatives.
By end user, hospitals & ambulatory surgery centers held the largest share in the neuromodulation market in 2024.
By end users, the neuromodulation market is divided into hospitals & ambulatory surgery centers, clinics & physiotherapy centers, and other end users. Among these, the hospitals & ambulatory surgery centers segment held the largest market share in 2024 for neuromodulation. Hospitals and ambulatory surgery centers dominate because of their access to specialized surgical facilities, trained clinicians, and comprehensive care required for complex neuromodulation procedures. Established reimbursement frameworks and high procedure volumes further strengthen their leadership in providing these services technologies.
North America dominated the global neuromodulation market in 2024.
The neuromodulation market is divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest market share for neuromodulation. This is due to its well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong regulatory support for neuromodulation devices. Additionally, significant R&D investments and a large patient population with chronic neurological and pain conditions further propel the market growth.
Key Players
Prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova PLC (UK), Nevro Corp (US), NeuroPace, Inc. (US), Bioventus (US), electroCore, Inc. (US), Helius Medical Technologies, Inc. (US), and Neuronetics (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Neuromodulation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
